Association of the functional BCL-2 rs2279115 genetic variant and small cell lung cancer
- 187 Downloads
As a well-known oncogene, B cell lymphoma-2 (BCL-2) can promote cancer cell survival through preventing their apoptosis. Several functional BCL-2 single nucleotide polymorphisms (SNPs), such as rs2279115, rs1801018, and rs1564483, have been identified and might contribute to cancer susceptibility. However, the involvement of these SNPs in small cell lung cancer (SCLC) was still unclear. As a result, we investigated associations between these three genetic variants and SCLC risk in a case-control design. Genotypes were determined in two independent case-control sets consisted of 520 SCLC patients and 1040 controls from two medical centers. Odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated utilizing unconditional logistic regression. We found that only BCL-2 rs2279115 genetic variant significantly contributed to decreased SCLC risk in Chinese Han populations, with the rs2279115 A allele as the protective allele. Stratified analyses of association between BCL2 rs2279115 SNP and SCLC risk indicated that the functional polymorphism was only significantly associated with decreased risk of the limited stage SCLC but not the extensive stage disease. Our results indicate that the BCL-2 rs2279115 genetic variant was associated with SCLC risk in Chinese populations and support the hypothesis that SNPs in regulatory regions of oncogenes might contribute to cancer susceptibility.
KeywordsBCL-2 Polymorphism SCLC Susceptibility
This study was financially supported by the National High-Tech Research and Development Program of China (2015AA020950), National Natural Science Foundation of China (31271382, 81201586), the Fundamental Research Funds for the Central Universities (YS1407), the open project of State Key Laboratory of Molecular Oncology (SKL-KF-2015-05), Beijing Higher Education Young Elite Teacher Project (YETP0521), and Innovation and Promotion Project of Beijing University of Chemical Technology.
Conflicts of interest